Efficacy of topical bevacizumab 0.05% eye drops in dry eye disease: A double-masked, randomized trial

scientific article published on 05 June 2020

Efficacy of topical bevacizumab 0.05% eye drops in dry eye disease: A double-masked, randomized trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PONE.0234186
P932PMC publication ID7274382
P698PubMed publication ID32502179

P50authorLita UthaithammaratQ96165063
P2093author name stringNgamjit Kasetsuwan
Usanee Reinprayoon
Kanawat Chantaralawan
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue6
P921main subjectbevacizumabQ413299
eye diseaseQ3041498
P304page(s)e0234186
P577publication date2020-06-05
P1433published inPLOS OneQ564954
P1476titleEfficacy of topical bevacizumab 0.05% eye drops in dry eye disease: A double-masked, randomized trial
P478volume15

Search more.